Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France
Authors
Keywords
-
Journal
DRUG SAFETY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-06
DOI
10.1007/s40264-023-01359-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update
- (2023) Patricia García-Abeijon et al. DRUG SAFETY
- Factors associated with underreporting of adverse drug reactions by patients: a systematic review
- (2023) Catarina Costa et al. International Journal of Clinical Pharmacy
- Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis
- (2023) Clément Mathieu et al. Frontiers in Pharmacology
- An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance
- (2023) Benjamin Micallef et al. DRUG SAFETY
- Signaling COVID-19 Vaccine Adverse Events
- (2022) Rave Harpaz et al. DRUG SAFETY
- Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study
- (2022) Clément Mathieu et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Global COVID ‐19 Pandemic and Reporting Behavior ‐ An Analysis of the Food and Drug Administration Adverse Events Reporting System ( FAERS )
- (2021) Michael Dörks et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- French organization for the Pharmacovigilance of COVID-19 vaccines: a major challenge
- (2021) Clémence Lacroix et al. THERAPIE
- Effects of the COVID-19 Pandemic on Spontaneous Reporting: Global and National Time-Series Analyses
- (2020) Manfred Hauben et al. CLINICAL THERAPEUTICS
- The French Levothyrox® crisis: We did the best we could but...The Levotyrox® case
- (2019) Stéphane Mouly et al. THERAPIE
- Adverse events reported for Mirena levonorgestrel‐releasing intrauterine device in France and impact of media coverage
- (2019) Claire Langlade et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacovigilance – The next chapter
- (2019) Nicholas Moore et al. THERAPIE
- Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
- (2018) E. Raschi et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Les études cas–non cas : principe, méthodes, biais et interprétations
- (2018) Jean-Luc Faillie THERAPIE
- Spontaneous adverse-events notifications by patients subsequent to the marketing of a new formulation of Levothyrox® amidst a drug media crisis: atypical profile as compared with other drugs
- (2018) Delphine Viard et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Impact of the “French Levothyrox crisis” on signal detection in the World Health Organization pharmacovigilance database
- (2018) Charles Khouri et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- French pharmacovigilance: Missions, organization and perspectives
- (2016) Thierry Vial THERAPIE
- A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases
- (2015) Mickael Arnaud et al. DRUG SAFETY
- Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations
- (2015) Racquel Jandoc et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank
- (2014) Ola Caster et al. DRUG SAFETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search